Author

C. M. Telleria

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

A. A. Goyeneche· 2 shared A. S. Noman· 1 shared J. V. Burnier· 1 shared M. A. Lisio· 1 shared M. R. Subeha· 1 shared P. Bustamante· 1 shared S. J. Ritch· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. A. Goyeneche

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 7, 2022

The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone

S. J. Ritch, A. S. Noman, A. A. Goyeneche, C. M. Telleria

This study compares metastatic abilities of high-grade serous ovarian cancer cells across disease stages in 2D and 3D assays and shows mifepristone inhibits these behaviors in all models.

DOI 10.1101/2022.05.07.491021

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCancersPeer-reviewedDec 26, 2021

Nelfinavir induces cytotoxicity towards high-grade serous ovarian cancer cells, involving induction of the unfolded protein response, modulation of protein synthesis, DNA damage, lysosomal impairment, and potentiation of toxicity caused by proteasome inhibition

M. R. Subeha, A. A. Goyeneche, P. Bustamante…·C. M. Telleria

This study shows nelfinavir induces cytotoxicity in high-grade serous ovarian cancer cells through DNA damage, unfolded protein response, and synergistic effects with proteasome inhibitors.

DOI 10.3390/cancers14010099

humanproteomics

𝕏 PostBluesky